Patents by Inventor Dallas Hughes

Dallas Hughes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11891415
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: February 6, 2024
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11851458
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: December 26, 2023
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20220289793
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: October 13, 2021
    Publication date: September 15, 2022
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20220185845
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: November 11, 2021
    Publication date: June 16, 2022
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11203616
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: December 21, 2021
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11174290
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: November 16, 2021
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20200031871
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: March 30, 2018
    Publication date: January 30, 2020
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Publication number: 20200024310
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: August 1, 2019
    Publication date: January 23, 2020
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 10414800
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: September 17, 2019
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20170121372
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: June 15, 2016
    Publication date: May 4, 2017
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 9402878
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: August 2, 2016
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20150313960
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: July 1, 2015
    Publication date: November 5, 2015
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 9163065
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: October 20, 2015
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20140194345
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Application
    Filed: December 3, 2013
    Publication date: July 10, 2014
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullenec, Kim Lewis
  • Publication number: 20120175255
    Abstract: The invention relates to capillary electrophoresis-based methods for screening compound libraries for affinity lig- ands, in particular weak-binding ligands.
    Type: Application
    Filed: September 20, 2010
    Publication date: July 12, 2012
    Inventor: Dallas Hughes
  • Publication number: 20080096903
    Abstract: Sulfamoyl-containing compounds are disclosed, having utility as inhibitors of disease-related targets, such as Heat Shock Protein 90 (HSP90), and which are useful for treating disorders, e.g., proliferative disorders, including HSP90-mediated disorders. Methods for preparing and using the disclosed compounds are also described.
    Type: Application
    Filed: October 19, 2007
    Publication date: April 24, 2008
    Applicant: Wyeth
    Inventors: Jianxin Chen, Gerhard Sperl, Vincent Gullo, Lalitha Sista, Dallas Hughes, Yucai Peng, William Pierceall, Andrew Weiskopf, Jeremy Levin, Russell Dushin, Mercy Otteng